ClinicalTrials.gg
CompletedNCT06516107CPUpdated Feb 19, 2025

Understanding Parental Stress and Quality of Life in Families of Children With Diplegic Cerebral Palsy: Key Influencing Factors

An observational study in Stress, Diaplegia and Cerebral Palsy, sponsored by Sinai University. Completed at 1 site in Egypt. Per ClinicalTrials.gov, last updated 2025-02-19.

Sponsored by Sinai University · Observational

Study type
Observational
Model
Family-based
Time perspective
Cross-sectional
Enrollment
100
Sex
All
01

Study summary

PURPOSE:

To estimate the relationships between the child, parents, and family factors and parent stress and QoL among parents of children with diplegic CP.

BACKGROUND:

Cerebral palsy (CP) is considered the primary reason of motor impairment among children worldwide. Compared to parents of typically developing children, parents of children with cerebral palsy (CP) experience higher levels of stress and reduced quality of life (QoL).

HYPOTHESES:

There is no relation between the level of functional impairment among children with diplegic CP and their parental stress and QOL.

RESEARCH QUESTION:

Is there a relationship between the level of functional impairment among children with diplegic CP and the degree of their parental stress and quality of life?

02

Conditions studied

  • Stress
  • Diaplegia
  • Cerebral Palsy

Browse trials for

Keywords

  • Cerebral palsy
  • Quality of life
  • Parental stress
03

In context

Cerebral Palsy

1,891 studies on the registry are indexed under Cerebral Palsy; 439 are open to participants now.

This study's enrollment of 100 is above the median of 63 across 465 observational studies indexed under Cerebral Palsy.

Browse Cerebral Palsy studies →

Lead sponsor

Sinai University is the lead sponsor of 24 studies on the registry; 11 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Parents of Children with diplegic CP age range 2 to 4.5

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Parents of children between the ages of 2 and 4.8 who had been diagnosed with diplegic CP.

    • Parents of children with diplegic CP who were in a stable clinical and medical state.

Exclusion criteria

Exclusion Criteria:

  • parents of children with behavioral problem.
  • a history of ongoing heart disease
  • a botulinum toxin injection within the six months previous to the study
  • chronic chest disease
  • significant visual or auditory impairment
  • parents with limited literacy
05

Study design

Observational model
Family-based
Time perspective
Cross-sectional
Enrollment
100 participants (actual)
Target follow-up
1 Day
Patient registry
Yes

Groups and cohorts

  • 1 Group of parents of children with diplegic cerebral palsy

    Parents of children between the ages of 2 and 4.8 who had been diagnosed with diplegic CP and were in a stable clinical and medical state will be included in this study. However, parents of children with behavioral problems, a history of ongoing heart disease, a botulinum toxin injection within the six months previous to the study, chronic chest disease, significant visual or auditory impairment, or parents with limited literacy will not allowed to participate in the study

06

What researchers measure

Primary outcomes

  1. Parental stress

    Parental stress will be measured by the Arabic version of the parent stress index-short form (PSI-SF) . PSI-SF is a self-reported questionnaire with 36 items rated on a 5-point Likert scale (strongly agree or strongly disagree). The score of the measure ranged between 36 and 180, and a lower score indicates a better outcome.

    Time frame: 1 day - one session

Secondary outcomes

  1. Quality of life of parents

    Quality of life (QoL) will be measured by the family impact module (PedsQL) and quality-of-life inventory.

    Time frame: 1 day - one session

  2. Gross motor impairments

    Gross motor impairments will be assessed via gross motor classification system

    Time frame: 1 day - one session

07

Study locations

1 site
  • Sinai University
    Ismailia, Egypt
08

References and documents

Publications

  • Dubois-Comtois K, St-Onge J, St-Laurent D, Cyr C. Paternal distress and child behavior problems in low-SES families: Quality of father-child interactions as mediators. J Fam Psychol. 2021 Sep;35(6):725-734. doi: 10.1037/fam0000830. Epub 2021 Mar 11. PubMed 33705176 ↗
  • Villamor E, Tedroff K, Peterson M, Johansson S, Neovius M, Petersson G, Cnattingius S. Association Between Maternal Body Mass Index in Early Pregnancy and Incidence of Cerebral Palsy. JAMA. 2017 Mar 7;317(9):925-936. doi: 10.1001/jama.2017.0945. PubMed 28267854 ↗

Individual participant data

Plan to share: Undecided — Privacy Concerns: IPD can be very detailed and contain sensitive information about participants, such as their medical history, diagnoses, and treatment responses. Sharing this data could potentially identify participants, even if it is de-identified. This can be a major concern, especially for studies involving rare diseases or conditions. Data Security: Making IPD publicly available raises risks of data breaches or unauthorized access. Researchers need to be confident they have robust security measures in place to protect sensitive participant information.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jun 2024 to primary completion in Aug 2024, 1 month.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 12, 2024
First posted
Jul 23, 2024
StartActual
Jun 5, 2024
Primary completionActual
Aug 1, 2024
CompletionActual
Aug 1, 2024
Last update
Feb 19, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 19, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06516107
Lead sponsor
Sinai University
Responsible party
Alaa Noureldeen Kora (Lecturer at the Department of Physical Therapy for Pediatrics and Pediatric Surgery, Sinai University) — Principal investigator
First posted
Jul 23, 2024
Start date
Jun 5, 2024
Primary completion
Aug 1, 2024
Completion
Aug 1, 2024
Last update
Feb 19, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion